As Executive Director and Head of Bioscience, Chronic Obstructive Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF), 呼吸 & 免疫学(右&I), I lead more than 50 scientists across three sites in the UK, 美国和瑞典, supporting a portfolio of drug discovery and development projects from target identification through to completion of phase 2B studies. I am also a member of the Leadership Team and 研究 Board governing 澳门在线赌城娱乐’s 呼吸 & 免疫学(右&一)事业部.
With over 25 years’ experience in biopharmaceutical research and development, I have held positions including Senior Principle Scientist, 项目负责人, Head of Drug 新陈代谢 and Pharmacokinetics and Head of Bioscience. With over 45 peer reviewed publications, I am passionate about scientific discovery and supporting the scientists with whom I work through providing clarity, simplicity and time for science.
COPD和IPF, the teams I lead are focused on developing a pre-clinical portfolio targeting disease modification and cure. The long-term goal is to make discoveries that allow reversal of lung diseases, allowing patients to live healthy lives for longer.
I am a biochemistry graduate and also have a PhD in protein biochemistry and enzyme kinetics from the University of Birmingham, UK.
I am passionate about problem solving and addressing the granular details of scientific research so that we make truly informed clinical investment decisions. I feel privileged to work for an organisation that has scientific excellence as a core value underpinning investment decisions. 澳门在线赌城娱乐 really does have the desire to make a transformative difference to patients’ lives.
电流的作用
2018年至今
2014 – 2019
2018 – 2020
2013 – 2014
2007 – 2011
Veeva ID: Z4-51941
Date of preparation: January 2023